Pluri Inc. (NASDAQ:PLUR) Short Interest Up 40.7% in May

Pluri Inc. (NASDAQ:PLUR) was the target of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 33,900 shares, a growth of 40.7% from the May 15th total of 24,100 shares. Approximately 0.8% of the shares of the company are short sold. Based on an average trading volume of 18,400 shares, the days-to-cover ratio is presently 1.8 days.

Pluri Stock Performance

Shares of Pluri stock traded down $0.15 on Monday, hitting $4.25. The stock had a trading volume of 19,689 shares, compared to its average volume of 16,198. The stock has a market cap of $33.29 million, a price-to-earnings ratio of -0.76 and a beta of 0.77. The business’s 50 day moving average is $4.67 and its two-hundred day moving average is $4.56. The company has a quick ratio of 5.04, a current ratio of 5.04 and a debt-to-equity ratio of 4.44. Pluri has a twelve month low of $3.33 and a twelve month high of $7.13.

Pluri (NASDAQ:PLUR) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.94) EPS for the quarter. Pluri had a negative net margin of 3,551.49% and a negative return on equity of 2,778.13%. The firm had revenue of $0.43 million during the quarter.

Analysts Set New Price Targets

Several brokerages have issued reports on PLUR. Industrial Alliance Securities set a $12.00 price target on Pluri in a report on Monday, June 2nd. Alliance Global Partners started coverage on shares of Pluri in a research note on Monday, June 2nd. They set a “buy” rating and a $12.00 target price for the company.

Hedge Funds Weigh In On Pluri

An institutional investor recently raised its position in Pluri stock. Renaissance Technologies LLC lifted its holdings in shares of Pluri Inc. (NASDAQ:PLUR) by 38.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,025 shares of the company’s stock after purchasing an additional 9,400 shares during the quarter. Renaissance Technologies LLC owned 0.61% of Pluri worth $145,000 as of its most recent SEC filing. 16.59% of the stock is owned by hedge funds and other institutional investors.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.